A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Clinical trial NCT01311050 · UNKNOWN
Trial details
- NCT number
- NCT01311050
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2009-01-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.